Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer

Por Masuda, Hiroshi, Kaga, Kanya, Inahara, Masahiko, Araki, Kazuhiro, Kojima, Satoko, Naya, Yukio, Takano, Makoto
Publicado no Urol Case Rep (2017)

Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

Por Saeki, Toshiaki, Araki, Kazuhiro, Shimada, Ken, Shigekawa, Takashi, Nakayama, Hirofumi, Segawa, Yoshihiko, Mukai, Hirofumi
Publicado no Int Cancer Conf J (2016)

Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes

Por FUKADA, IPPEI, ARAKI, KAZUHIRO, KOBAYASHI, KOKORO, KOBAYASHI, TAKAYUKI, HORII, RIE, AKIYAMA, FUTOSHI, TAKAHASHI, SHUNJI, IWASE, TAKUJI, ITO, YOSHINORI
Publicado no Oncol Lett (2016)

Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer

Por Fukada, Ippei, Araki, Kazuhiro, Kobayashi, Kokoro, Shibayama, Tomoko, Hatano, Masaru, Takahashi, Shunji, Iwase, Takuji, Ohno, Shinji, Ito, Yoshinori
Publicado no Springerplus (2016)

False‐positive (123)I‐metaiodobenzylguanidine scan in a patient with renal cell carcinoma: A case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical...

Por Suyama, Takahito, Kanesaka, Manato, Fujimoto, Ayumi, Otsuka, Kotaro, Hou, Kyokushin, Araki, Kazuhiro, Masuda, Hiroshi, Kojima, Satoko, Yamazaki, Kazuto, Naya, Yukio
Publicado no IJU Case Rep (2020)

PSA response following the ‘steroid switch’ in patients with castration-resistant prostate cancer treated with abiraterone: A case report

Por Kato, Tomonori, Kojima, Satoko, Fujimoto, Ayumi, Otsuka, Kotaro, Suyama, Takahito, Hou, Kyokushin, Araki, Kazuhiro, Masuda, Hiroshi, Yamazaki, Kazuto, Komiya, Akira, Naya, Yukio
Publicado no Oncol Lett (2018)

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab an...

Por Araki, Kazuhiro, Ito, Yoshinori, Fukada, Ippei, Kobayashi, Kokoro, Miyagawa, Yoshimasa, Imamura, Michiko, Kira, Ayako, Takatsuka, Yuichi, Egawa, Chiyomi, Suwa, Hirofumi, Ohno, Shinji, Miyoshi, Yasuo
Publicado no BMC Cancer (2018)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer

Por Fukada, Ippei, Araki, Kazuhiro, Kobayashi, Kokoro, Shibayama, Tomoko, Takahashi, Shunji, Horii, Rie, Akiyama, Futoshi, Iwase, Takuji, Ohno, Shinji, Hatake, Kiyohiko, Hozumi, Yasuo, Sata, Naohiro, Ito, Yoshinori
Publicado no PLoS One (2016)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of (18)F-deoxyglucose levels on positron emission tomogr...

Por Nishimukai, Arisa, Inoue, Natsuko, Kira, Ayako, Takeda, Masashi, Morimoto, Koji, Araki, Kazuhiro, Kitajima, Kazuhiro, Watanabe, Takahiro, Hirota, Seiichi, Katagiri, Toyomasa, Nakamori, Shoji, Akazawa, Kouhei, Miyoshi, Yasuo
Publicado no PLoS One (2017)

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes

Por Imamura, Michiko, Morimoto, Takashi, Nomura, Takashi, Michishita, Shintaro, Nishimukai, Arisa, Higuchi, Tomoko, Fujimoto, Yukie, Miyagawa, Yoshimasa, Kira, Ayako, Murase, Keiko, Araki, Kazuhiro, Takatsuka, Yuichi, Oh, Koshi, Masai, Yoshikazu, Akazawa, Kouhei, Miyoshi, Yasuo
Publicado no World J Surg Oncol (2018)

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastat...

Por Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Publicado no Trials (2020)

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advan...

Por Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Publicado no Trials (2020)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients

Por Makita, Masujiro, Sakai, Takehiko, Kataoka, Akemi, Kitagawa, Dai, Ogiya, Akiko, Morizono, Hidetomo, Miyagi, Yumi, Iijima, Kotaro, Kobayashi, Kokoro, Kobayashi, Takayuki, Fukada, Ippei, Araki, Kazuhiro, Takahashi, Shunji, Ito, Yoshinori, Gomi, Naoya, Oguchi, Masahiko, Kita, Mizuho, Arai, Masami, Akiyama, Futoshi, Iwase, Takuji
Publicado no Springerplus (2015)